Implementation of a Vaccination Program Based on Epidemic Geospatial Attributes: COVID-19 Pandemic in Ohio as a Case Study and Proof of Concept.

COVID-19 disease mapping geospatial attributes mathematical model spatial epidemiology vaccination program

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
25 Oct 2021
Historique:
received: 14 09 2021
revised: 05 10 2021
accepted: 21 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Geospatial vaccine uptake is a critical factor in designing strategies that maximize the population-level impact of a vaccination program. This study uses an innovative spatiotemporal model to assess the impact of vaccination distribution strategies based on disease geospatial attributes and population-level risk assessment. For proof of concept, we adapted a spatially explicit COVID-19 model to investigate a hypothetical geospatial targeting of COVID-19 vaccine rollout in Ohio, United States, at the early phase of COVID-19 pandemic. The population-level deterministic compartmental model, incorporating spatial-geographic components at the county level, was formulated using a set of differential equations stratifying the population according to vaccination status and disease epidemiological characteristics. Three different hypothetical scenarios focusing on geographical subpopulation targeting (areas with high versus low infection intensity) were investigated. Our results suggest that a vaccine program that distributes vaccines equally across the entire state effectively averts infections and hospitalizations (2954 and 165 cases, respectively). However, in a context with equitable vaccine allocation, the number of COVID-19 cases in high infection intensity areas will remain high; the cumulative number of cases remained >30,000 cases. A vaccine program that initially targets high infection intensity areas has the most significant impact in reducing new COVID-19 cases and infection-related hospitalizations (3756 and 213 infections, respectively). Our approach demonstrates the importance of factoring geospatial attributes to the design and implementation of vaccination programs in a context with limited resources during the early stage of the vaccine rollout.

Identifiants

pubmed: 34835173
pii: vaccines9111242
doi: 10.3390/vaccines9111242
pmc: PMC8625927
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Qatar National Research Fund
ID : 10-1208-160017

Références

Int J Med Inform. 2017 Nov;107:48-55
pubmed: 29029691
Clin Transl Sci. 2011 Feb;4(1):48-54
pubmed: 21348956
Lancet Public Health. 2020 Apr;5(4):e223-e234
pubmed: 32057317
BMJ Glob Health. 2019 Nov 05;4(6):e001922
pubmed: 31799003
Vaccine. 2020 Feb 5;38(6):1408-1415
pubmed: 31924428
Sci Adv. 2020 Nov 4;6(45):
pubmed: 33148655
Lancet. 2020 Apr 18;395(10232):1243-1244
pubmed: 32305087
J Infect Dis. 2017 Jul 1;216(suppl_1):S337-S342
pubmed: 28838181
Ann Epidemiol. 2021 Jul;59:16-20
pubmed: 33894385
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8767-72
pubmed: 21518855
Lancet. 2021 Jan 30;397(10272):398-408
pubmed: 33516338
Int J Environ Res Public Health. 2021 Apr 12;18(8):
pubmed: 33921217
Int J Infect Dis. 2020 Jul;96:222-227
pubmed: 32371191
BMJ Glob Health. 2021 Apr;6(4):
pubmed: 33883186
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244365
Lancet Glob Health. 2020 Feb;8(2):e177-e178
pubmed: 31981552
Influenza Other Respir Viruses. 2018 May;12(3):344-352
pubmed: 29405575
Vaccine. 2020 Feb 29;38 Suppl 1:A118-A126
pubmed: 31879125
Hum Vaccin Immunother. 2013 Dec;9(12):2649-53
pubmed: 23982270
Health Place. 2020 Jul;64:102404
pubmed: 32736312
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):465-471
pubmed: 32298250
J R Soc Interface. 2007 Oct 22;4(16):935-48
pubmed: 17490941
Arch Dis Child. 2016 Feb;101(2):140-6
pubmed: 26342094
J Infect Dis. 2014 Nov 1;210 Suppl 1:S102-10
pubmed: 25316823
Glob Epidemiol. 2020 Nov;2:100042
pubmed: 33235991
Front Immunol. 2018 Sep 19;9:1963
pubmed: 30283434

Auteurs

Susanne F Awad (SF)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha 24144, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Doha 24144, Qatar.
Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.

Godfrey Musuka (G)

ICAP, Columbia University, Harare, Zimbabwe.

Zindoga Mukandavire (Z)

Centre for Data Science and Artificial Intelligence, Emirates Aviation University, Dubai 53044, United Arab Emirates.

Dillon Froass (D)

College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.

Neil J MacKinnon (NJ)

Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

Diego F Cuadros (DF)

Department of Geography and Geographic Information Science, University of Cincinnati, Cincinnati, OH 45221, USA.
Health Geography and Disease Modeling Laboratory, University of Cincinnati, Cincinnati, OH 45221, USA.

Classifications MeSH